Cell isolation and biomedical research tools with GMP manufacturing at scale
Miltenyi Biotec operates a diversified biotech stack anchored in SAP (FI/CO, SD, BW) and ServiceNow, with engineering and manufacturing teams driving production-facility buildout and CAR-T cell platform work. The hiring composition—nearly half engineering and manufacturing roles, with decelerating velocity—reflects a company in operational scaling rather than growth acceleration; pain points cluster around GMP compliance, batch release timelines, and production-capacity constraints, signaling maturation from R&D into regulated manufacturing.
Notable leadership hires: Marketing Director, Director, MACS Services
Miltenyi Biotec develops cell isolation, sorting, and sample-preparation technologies for biomedical research and personalized medicine across immunology, stem-cell, cancer, and neuroscience applications. The company operates across more than 50 countries with over 4,700 employees spanning natural sciences, engineering, and informatics. Current operational focus includes building a modern production facility for clinical reagents, decentralized manufacturing support for cell and gene therapy (CGT), and CAR-T cell projects, alongside continuous GMP compliance and supply-chain optimization work. The tech footprint centers on enterprise systems (SAP, ServiceNow) and internal platform development (observability, connectivity).
SAP (FI/CO, SD, BW, Cloud Platform), ServiceNow, Jira, Confluence, Figma, Adobe Creative Cloud, C++, Java, TypeScript, Go, and NATS messaging. Currently adopting XML.
Building a modern production facility for clinical reagents, scaling decentralized manufacturing for CGT, developing CAR-T cell platforms, implementing GMP documentation and CAPA processes, and building observability and connectivity platforms.
Other companies in the same industry, closest in size